SEC Form 3 · accession 0001710420-17-000002

Avant Diagnostics, Inc · AVDX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Jun 19, 2017

Accepted (ET)

Jun 28, 2017 · 1:56 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001451929

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	13,283,333	I	Through Infusion 51a, LP
Common Stock	holding	—	—		—	4,075,000	I	Through International Infusion, LP

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Senior Secured Convertible Promissory Notes	$0.15	holding	—	—	—	Nov 16, 2016	Jan 15, 2018	Common Stock	—	—	I
Senior Secured Convertible Promissory Notes	$0.15	holding	—	—	—	Dec 2, 2016	Jan 15, 2018	Common Stock	—	—	I
Senior Secured Convertible Promissory Notes	$0.15	holding	—	—	—	Dec 6, 2016	Jan 15, 2018	Common Stock	—	—	I
Senior Secured Convertible Promissory Notes	$0.15	holding	—	—	—	Dec 12, 2016	Jan 15, 2018	Common Stock	—	—	I
Senior Secured Convertible Promissory Notes	$0.15	holding	—	—	—	Dec 13, 2016	Jan 15, 2018	Common Stock	—	—	I
Senior Secured Convertible Promissory Notes	$0.15	holding	—	—	—	Nov 16, 2016	Jan 15, 2018	Common Stock	—	—	I
Senior Secured Convertible Promissory Notes	$0.15	holding	—	—	—	Dec 23, 2016	Jan 15, 2018	Common Stock	—	—	I
Warrants^F2	$0.06	holding	—	—	—	Jun 19, 2017	Jun 19, 2022	Common Stock	10,833,333	—	I
Common Stock Purchase Rights	$0.06	holding	—	—	—	Jan 19, 2019	Jun 19, 2022	Common Stock	43,333,333	—	I
Senior Secured Convertible Promissory Notes	$0.06	holding	—	—	—	Jun 19, 2017	Jun 19, 2020	Common Stock	—	—	I

F1Warrants were acquired on same day through two different transactions involving 10,000,000 and 833,333 warrants.
F2Common Stock Purchase Rights were acquired on the same day in two different transactions involving 40,000,000 and 3,333,333 Common Stock Purchase Rights.